Kansas Business Today
SEE OTHER BRANDS

Your business and economy news reporter from Kansas

Kansas Business Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.

Press releases published on May 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).   Such investors are advised to contact Danielle Peyton at  …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cleveland-Cliffs Inc. - CLF

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cleveland-Cliffs Inc. - CLF

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or the “Company”) (NYSE: CLF).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines - CODI

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines - CODI

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Compass Diversified Holdings (“CODI” or the “Company”) (NYSE: CODI).   Such investors are advised to contact Danielle Peyton at newaction@ …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Krispy Kreme, Inc. - DNUT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Krispy Kreme, Inc. - DNUT

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - CABO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - CABO

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Cable One, Inc. (“Cable One” or the “Company”) (NYSE: CABO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Take-Two Interactive Software, Inc. - TTWO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Take-Two Interactive Software, Inc. - TTWO

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Take-Two Interactive Software, Inc. (“Take-Two” or the “Company”) (NASDAQ: TTWO).  Such investors are advised to contact Danielle Peyton at newaction …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART).   Such investors are advised to contact Danielle Peyton at …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amerant Bancorp Inc. - AMTB

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amerant Bancorp Inc. - AMTB

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FTI Consulting, Inc. - FCN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FTI Consulting, Inc. - FCN

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  FTI Consulting, Inc. (“FTI” or the “Company”) (NYSE: FCN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581 …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wabash National Corporation - WNC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wabash National Corporation - WNC

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  …

 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jack in the Box Inc. - JACK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jack in the Box Inc. - JACK

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Jack in the Box Inc. (“Jack in the Box” or the “Company”) (NASDAQ: JACK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of T-Mobile US, Inc. - TMUS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of T-Mobile US, Inc. - TMUS

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  T-Mobile US, Inc. (“T-Mobile” or the “Company”) (NASDAQ: TMUS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Senti Biosciences, Inc. - SNTI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Senti Biosciences, Inc. - SNTI

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Senti Biosciences, Inc. (“Senti” or the “Company”) (NASDAQ: SNTI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service